Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 62

Sort by

Sort Order Select

Journal Articles

Imbalanced Expression of TACI Isoforms Regulated By TNFRSF13B Variants Promotes the Progression of Epstein-Barr Virus-Associated Lymphoproliferative Diseases

Xinyue Deng, Qiang Gao, Kefeng Shen, Wei Mu, Tong Ge, Jiachen Wang, Jianfeng Zhou, Yicheng Zhang, Dengju Li, Min Xiao

Blood (2024) 144 (Supplement 1): 125.

https://doi.org/10.1182/blood-2024-193440

Published: 2024

Journal Articles

Real-World Efficacy and Safety of Orelabrutinib in Marginal Zone Lymphoma: A Retrospective Analysis of Mucosa-Associated Lymphoid Tissue Lymphoma Patients

Miao Zheng, Tongjuan Li, Zetong Hong, Min Liu, Yaxian Ma, Qing Yin, Zhaoyang Hong, Lei Zhao, Jia Wei, Yicheng Zhang

Blood (2024) 144 (Supplement 1): 6299.

https://doi.org/10.1182/blood-2024-204518

Published: 2024

Journal Articles

A Phase II Study to Evaluate the Efficacy and Safety of Pimicotinib (ABSK021) in Chronic Graft Versus Host Disease (cGvHD) after 1 or More Lines of Systemic Treatment

Xiaodong Mo, He Huang, Feng Chen, Yi Luo, Jia Chen, Erlie Jiang, Yicheng Zhang, Linghui Xia, Chengwei Luo Luo, Xinchuan Chen, Nainong Li, Ming Jiang, Sujun Gao, Dongqin Yang, Qingli Zuo, Yimin Chen, Li Yao, Pan Liang, Depei Wu

Blood (2024) 144 (Supplement 1): 99.

https://doi.org/10.1182/blood-2024-193191

Published: 2024

Journal Articles

Letermovir for Prevention of Cytomegalovirus Infection in Chinese Adult Allogeneic Hematopoietic Stem Cell Transplant Recipients: A Phase 3, Open-Label, Single-Arm Trial

Yun He, Lanping Xu, Yujun Dong, Xianmin Song, Yicheng Zhang, Erlie Jiang, Hu Yu, Ren Lin, Ying Wang, Xiaodan Guo, Weiwei Zhao, Cyrus Badshah

Blood (2024) 144 (Supplement 1): 7302.

https://doi.org/10.1182/blood-2024-199269

Published: 2024

Journal Articles

Reflecting In Vivo Spatio-Temporal Distribution Characteristics of CAR-T Cells through Real-World Clinical Samples

Man Zhang, Liting Chen, Caixia Chen, Jia Wei, Yicheng Zhang, Yi Xiao

Blood (2024) 144 (Supplement 1): 7125.

https://doi.org/10.1182/blood-2024-194628

Published: 2024

Journal Articles

Impact of Febrile Neutropenia on Mobilization Efficacy in Multiple Myeloma Patients and Post-Transplant Infection Risk in Lymphoma Patients: Insights from Real-World Multicenter Data

Hu Qian, Xinwei Wang, Liping Yang, Juan Peng, Jie Zhao, Shaolong He, Jin Zhao, Jiaqi Guo, Yuekun Fang, Fankai Meng, Yang Cao, Lifang Huang, Junni Wei, Liangming Ma, Li-Ping Su, Weiwei Tian, Yicheng Zhang, Jia Wei

Blood (2024) 144 (Supplement 1): 7834.

https://doi.org/10.1182/blood-2024-205222

Published: 2024

Journal Articles

Tandem CD19/20 CAR-T Showed Durable Efficacy in Patients with Relapsed/Refractory B-Cell Lymphoma: Interim Results from a Multicenter Phase I/II Trial

Jia Wei, Xiaoxi Zhou, Hui Luo, Yang Cao, Jiaqi Guo, Jie Zhao, Lifang Huang, Ang Zhang, Lihong Liu, Weiwei Tian, Yicheng Zhang

Blood (2024) 144 (Supplement 1): 3132.

https://doi.org/10.1182/blood-2024-205207

Published: 2024

Journal Articles

Comparison of Outcomes between Haploidentical and Matched Related Donors for Chronic Myelomonocytic Leukemia: A Multicenter Real-World Study

Blood (2024) 144 (Supplement 1): 2187.

https://doi.org/10.1182/blood-2024-206919

Published: 2024

Journal Articles

Proteomics and Single-Cell Transcriptomics Reveal Differentiation Patterns of pDC-like LSCs and Poor Prognosis in AML with pDC Expansion

Xingcheng Yang, Juan Peng, Lei Zhang, Yicheng Zhang, Xia Mao, Jue Wang, Jia Wei

Blood (2024) 144 (Supplement 1): 2935.

https://doi.org/10.1182/blood-2024-202707

Published: 2024

Journal Articles

A Phase 2 Clinical Trial of Anti-CD19 CAR-T (pCAR-19B) in Chinese Pediatric and Young Adult with Relapsed/Refractory (R/R) CD19+ B-ALL: The First Pivotal Study in an Asian Population

Blood (2024) 144 (Supplement 1): 4205.

https://doi.org/10.1182/blood-2024-206408

Published: 2024

Journal Articles

Prediction of Organs Toxicity during CAR T-Cell Therapy By Using Cell-Free DNA Markers

Liting Chen, Qiyang Han, Yan Zhang, Guodan Zeng, Yuekun Fang, Man Zhang, Jia Wei, Yicheng Zhang

Blood (2024) 144 (Supplement 1): 4782.

https://doi.org/10.1182/blood-2024-194685

Published: 2024

Journal Articles

3D Live Imaging and Phenotyping of the Subcellular Cytotoxicity in CAR-T Cell Immunotherapy

Liting Chen, Zhaofei Wang, Jie Wang, Jin Jin, Jia Wei, Yicheng Zhang, Peng Fei

Blood (2024) 144 (Supplement 1): 4781.

https://doi.org/10.1182/blood-2024-193597

Published: 2024

Journal Articles

High Serum ST2 Level Predicts Progression and Poor Prognosis of De novo myelodysplastic Syndrome

Juan Peng, Xingchen Yang, Chunrui Li, Yicheng Zhang, Ling Ma, Jia Wei

Blood (2023) 142 (Supplement 1): 6455.

https://doi.org/10.1182/blood-2023-183057

Published: 2023

Journal Articles

Recommendations on Minimal Residual Disease Monitoring in Acute Promyelocytic Leukemia Treated with Combination of All- Trans Retinoic Acid and Arsenic Trioxide

Blood (2023) 142 (Supplement 1): 2946.

https://doi.org/10.1182/blood-2023-184433

Published: 2023

Journal Articles

CD19/CD22 CAR T-Cell Therapy Following Autologous Transplantation Is an Optimizing Strategy in Relapsed/Refractory Central Nervous System Lymphoma

Qiuxia Yu, Daizi Gang, Jue Wang, Liang Huang, Chunrui Li, Yicheng Zhang, Xiaoxi Zhou, Yang Cao

Blood (2023) 142 (Supplement 1): 6855.

https://doi.org/10.1182/blood-2023-180363

Published: 2023

Journal Articles

Heterogeneity and Differentiation Patterns of pDC Cells in pDC-AML: A Novel Perspective from Single-Cell RNA Sequencing

Xingcheng Yang, Juan Peng, Chunrui Li, Yicheng Zhang, Xia Mao, Jue Wang, Jia Wei

Blood (2023) 142 (Supplement 1): 1568.

https://doi.org/10.1182/blood-2023-190826

Published: 2023

Journal Articles

A Prediction Model for Early Recurrence after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with CMML: A Nationwide Representative Multicenter Study

Blood (2023) 142 (Supplement 1): 4951.

https://doi.org/10.1182/blood-2023-184407

Published: 2023

Journal Articles

Olverembatinib Based Therapy in Recurrent Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia with BCR/ABL Mutation

Qiuxia Lv, Qiuxia Yu, Yang Cao, Jue Wang, Yicheng Zhang, Gaoxiang Wang, Zhenya Hong, Li Meng

Blood (2022) 140 (Supplement 1): 11688–11689.

https://doi.org/10.1182/blood-2022-157416

Published: 2022

Journal Articles

Soluble PD-L1 Predict Poor Outcome and Disease Progression in Patients with De Novo Myelodysplastic Syndrome

Xingchen Yang, Xiaoying Zhang, Yicheng Zhang, JIA Wei

Blood (2022) 140 (Supplement 1): 6896–6897.

https://doi.org/10.1182/blood-2022-166693

Published: 2022

Journal Articles

High Expression of Plasma IL-1β Levels and Transition of Regulatory T-Cell Subsets Correlate with Disease Progression in Myelodysplastic Syndrome

Xiaoying Zhang, Xingcheng Yang, Chunyan Wang, Liang Huang, Yicheng Zhang, JIA Wei

Blood (2022) 140 (Supplement 1): 9761–9762.

https://doi.org/10.1182/blood-2022-165179

Published: 2022

NARROW

Imbalanced Expression of TACI Isoforms Regulated By TNFRSF13B Variants Promotes the Progression of Epstein-Barr Virus-Associated Lymphoproliferative Diseases

Real-World Efficacy and Safety of Orelabrutinib in Marginal Zone Lymphoma: A Retrospective Analysis of Mucosa-Associated Lymphoid Tissue Lymphoma Patients

A Phase II Study to Evaluate the Efficacy and Safety of Pimicotinib (ABSK021) in Chronic Graft Versus Host Disease (cGvHD) after 1 or More Lines of Systemic Treatment

Letermovir for Prevention of Cytomegalovirus Infection in Chinese Adult Allogeneic Hematopoietic Stem Cell Transplant Recipients: A Phase 3, Open-Label, Single-Arm Trial

Reflecting In Vivo Spatio-Temporal Distribution Characteristics of CAR-T Cells through Real-World Clinical Samples

Impact of Febrile Neutropenia on Mobilization Efficacy in Multiple Myeloma Patients and Post-Transplant Infection Risk in Lymphoma Patients: Insights from Real-World Multicenter Data

Tandem CD19/20 CAR-T Showed Durable Efficacy in Patients with Relapsed/Refractory B-Cell Lymphoma: Interim Results from a Multicenter Phase I/II Trial

Comparison of Outcomes between Haploidentical and Matched Related Donors for Chronic Myelomonocytic Leukemia: A Multicenter Real-World Study

Proteomics and Single-Cell Transcriptomics Reveal Differentiation Patterns of pDC-like LSCs and Poor Prognosis in AML with pDC Expansion

A Phase 2 Clinical Trial of Anti-CD19 CAR-T (pCAR-19B) in Chinese Pediatric and Young Adult with Relapsed/Refractory (R/R) CD19+ B-ALL: The First Pivotal Study in an Asian Population

Prediction of Organs Toxicity during CAR T-Cell Therapy By Using Cell-Free DNA Markers

3D Live Imaging and Phenotyping of the Subcellular Cytotoxicity in CAR-T Cell Immunotherapy

High Serum ST2 Level Predicts Progression and Poor Prognosis of De novo myelodysplastic Syndrome

Recommendations on Minimal Residual Disease Monitoring in Acute Promyelocytic Leukemia Treated with Combination of All- Trans Retinoic Acid and Arsenic Trioxide

CD19/CD22 CAR T-Cell Therapy Following Autologous Transplantation Is an Optimizing Strategy in Relapsed/Refractory Central Nervous System Lymphoma

Heterogeneity and Differentiation Patterns of pDC Cells in pDC-AML: A Novel Perspective from Single-Cell RNA Sequencing

A Prediction Model for Early Recurrence after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with CMML: A Nationwide Representative Multicenter Study

Olverembatinib Based Therapy in Recurrent Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia with BCR/ABL Mutation

Soluble PD-L1 Predict Poor Outcome and Disease Progression in Patients with De Novo Myelodysplastic Syndrome

High Expression of Plasma IL-1β Levels and Transition of Regulatory T-Cell Subsets Correlate with Disease Progression in Myelodysplastic Syndrome

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only